| Mr Fareed Ismail, RPH | |
|
17 N Pearl St, Albany, NY 12207-2701 | |
| (518) 434-6024 | |
| (518) 626-0859 |
| Full Name | Mr Fareed Ismail |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 17 N Pearl St, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386820728 | NPI | - | NPPES |
| 1542561 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 048999 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Fareed Ismail, RPH 17 N Pearl St, Albany, NY 12207-2701 Ph: (518) 434-6024 | Mr Fareed Ismail, RPH 17 N Pearl St, Albany, NY 12207-2701 Ph: (518) 434-6024 |
News Archive
Arterial stiffness is one of the early signs of cardiovascular disease, and arterial stiffening has been observed in children.
The Christian Science Monitor: "Should the US government mount a comprehensive effort to evaluate the strengths and weaknesses of various treatments for health conditions? That question is at the heart of a dispute over whether some provisions in the healthcare reform bills now under consideration in Congress eventually might lead to the rationing of care. At issue is comparative effectiveness research, which tries to figure out just how well drugs, medical devices, and surgical techniques work, compared with alternatives. Both the House and current Senate versions of health legislation would expand exisitng federal efforts in this area."
Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong.
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.
Swiss researchers report that patients with neovascular age-related macular degeneration (nAMD) experience increased incidence of outer retinal tubulation over time, despite treatment with a vascular endothelial growth factor blocker.
› Verified 6 days ago
Muthuvappa Ahamed Naina, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 493 Delaware Avenue, Rite-aid #10694, Albany, NY 12209 Phone: 518-472-1206 | |
Abigail N Rudasill, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1616 | |
Dr. Michael Peter Daprano, PHARM. D, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Jupiter Ln, Albany, NY 12205 Phone: 518-689-2900 | |
Dr. Brian Chapin, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 Ormond St, Albany, NY 12203 Phone: 607-226-2277 | |
Abu Baker Durrani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 440 Magazine St, Albany, NY 12203 Phone: 910-581-8196 | |
Maria Sobieraj, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-381-6325 | |
Michael Vennard Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Western Ave, Albany, NY 12203 Phone: 518-869-0657 |